HEMOSTEMIX
Hemostemix Inc., a clinical-stage biotechnology company, develops, manufactures, and commercializes blood-derived cell therapies for medical conditions in Canada. It develops cell therapy products from the patient’s own blood, a relatively non-invasive source of therapeutic cells. The company’s lead product is ACP-01, which is in Phase II clinical trial for the treatment of critical limb ischemia. It is also developing various types of cells products, such as bone cell precursors, myocardial cell precursors, and neural cell precursors.
HEMOSTEMIX
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2006-01-01
Address:
Blackfalds, Alberta, Canada
Country:
Canada
Website Url:
http://www.hemostemix.com
Total Employee:
1+
Status:
Active
Contact:
403 471 6665
Total Funding:
11.26 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Abivax
Abivax is a pioneering biotech company.
Origin
Origin is a privately held, clinical-stage biotechnology company.
ArsenalBio
ArsenalBio is a programmable cell therapy company that offers advanced CAR T-cell therapies for solid tumors.
Atavistik Bio
Atavistik Bio is a biotechnology company that focuses on the discovery and development of novel therapies for metabolic diseases and cancer.
Atom Bioscience & Pharmaceutical
Atom Bioscience is a clinical-stage biotechnology company.
Biorem Inc.
Biorem is a pioneer environmental biotechnology company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Cardurion Pharmaceuticals
Cardurion is a Boston-based cardiovascular biotechnology company
Cellenkos
Cellenkos is a clinical stage biotech company.
Cocrystal Pharma
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics.
EpicentRx Inc
EpicentRx Inc is a clinical-stage immuno-oncology company.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
IconOVir Bio
IconOVir Bio is a preclinical-stage biotechnology company.
ImmuneID
ImmuneID is a precision immunology company.
Immunicom
Immunicom is a biotechnology company.
IMV
IMV is a clinical-stage immuno-oncology company.
January Therapeutics
January Therapeutics is a San Diego-based biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
MaveriX Oncology
MaveriX Oncology is a globally-orientated biotechnology company.
Nano Cures
Nano Cures is clinical-stage biotechnology and infectious disease immunity platform company.
NovaBiotics
NovaBiotics Ltd is a clinical-stage biotechnology company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Oerth Bio
Oerth Bio is a agriculture-focused biotech firm.
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
Opthea
Opthea Limited is a public Australian biotechnology company .
Origin Agritech
Origin Agritech is a leading agricultural biotechnology company.
People Corporation
People Corporation is publicly-traded on the TSX Venture Exchange under the symbol PEO.
Qualigen
Qualigen is a biotechnology company.
Relief Therapeutics
Relief Therapeutics is a clinical stage biotechnology company.
Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical stage biotechnology company.
SAB Biotherapeutics
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
SomaGenics
SomaGenics is a privately held biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Turnstone Biologics
Turnstone Biologics is a privately-held clinical stage biotech company.
Current Employees Featured
David Berman CFO @ Hemostemix
CFO
Richard T. Groome Special Advisor to The CEO @ Hemostemix
Special Advisor to The CEO
2022-04-01
Pierre Leimgruber Interim Chief Medical Officer @ Hemostemix
Interim Chief Medical Officer
Thomas A. Smeenk President & CEO, Co-Founder @ Hemostemix
President & CEO, Co-Founder
Founder
Stock Details
Investors List
Wood Capital
Wood Capital investment in Post-IPO Debt - Hemostemix
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-16 | Hemostemix Announces Rick Groome as Special Advisor to The CEO |
Official Site Inspections
http://www.hemostemix.com Semrush global rank: 7.74 M Semrush visits lastest month: 437
- Host name: host9a.ionblade.com
- IP address: 135.148.50.237
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Hemostemix"
Hemostemix - Crunchbase Company Profile & Funding
Hemostemix Inc., a clinical-stage biotechnology company, develops, manufactures, and commercializes blood-derived cell therapies for medical conditions in Canada. It develops cell …See details»
HEMOSTEMIX
Hemostemix Inc. (TSXV:HEM; OTCQB:HMTXF) is a public Canadian biotechnology company focused on the research, development and commercialization of blood-derived stem cell …See details»
Hemostemix Inc. - LinkedIn
Hemostemix is a public clinical-stage company that develops and commercializes innovative blood-derived cell therapies for medical conditions that are not adequately addressed by …See details»
Hemostemix Inc. (TSXV:HEM) Company Profile & Overview - Stock …
Feb 14, 2025 Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in …See details»
Hemostemix
Hemostemix is an autologous (patient’s own) stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including …See details»
Hemostemix. The Canadian Biotech that Could Change
Sep 11, 2021 Hemostemix Inc. (“Hemostemix”) (TSX Venture:HEM; OTCQB:HMTXF) is a publicly traded clinical-stage biotech company that develops and commercializes blood …See details»
Hemostemix is up-listing in the USA to generate liquidity
Jan 2, 2025 Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:HEM; FSE:2VF0; OTC:HMTXF), is pleased to announce it has applied to up-list its shares on the OTCQB …See details»
Get in touch with us at Hemostemix
Have any questions? Get in touch with us. Thomas A. Smeenk, BA President & CEO, Co-Founder Hemostemix Inc. TSXV:HEM 707 7th Ave. SW, Suite 1150 Calgary, AB T2P 3H6See details»
Hemostemix, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Feb 7, 2025 Hemostemix has organized with the principal investigators of its phase II trial up to 226 patients/month of CLTI specialist capacity. Globally, this provides individuals who are …See details»
Hemostemix Company Profile - Craft
Hemostemix is a biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. ACP-01, its clinical-stage …See details»
Hemostemix - Funding, Financials, Valuation & Investors
Hemostemix is registered under the ticker CVE:HEM . Hemostemix is funded by 3 investors. ... How much funding has this organization raised over time? Show . Announced Date . …See details»
Hemostemix Provides Corporate Update - Yahoo Finance
Feb 14, 2025 ABOUT HEMOSTEMIX. Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the …See details»
Hemostemix - Overview, News & Similar companies | ZoomInfo.com
Oct 22, 2023 Hemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease Calgary, Alberta--(Newsfile Corp. - …See details»
Shaping the Future of Medicine | Hemostemix - NAI 500
Sep 20, 2021 Hemostemix (TSXV: HEM; OTCQB: HMTXF) is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to …See details»
Hemostemix Provides Corporate Update - BioSpace
Feb 14, 2025 Calgary, Alberta--(Newsfile Corp. - February 13, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) announces that, at …See details»
HEMOSTEMIX INC (HEM.NE)
Mar 3, 2025 Find the latest HEMOSTEMIX INC (HEM.NE) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Investor Overview and Presentations - Hemostemix
If you are an investor and looking to invest in the biotechnology sector, then consider Hemostemix and its Stem Cell Therapeutics.See details»
Hemostemix Drives Social Media Awareness of Its Regenerative
Dec 17, 2024 About Hemostemix Founded in 2003, Hemostemix is a clinical-stage biotechnology company and winner of the World Economic Forum Technology Pioneer Award. …See details»
Hemostemix is Up-Listing in the USA to Generate Liquidity
Jan 2, 2025 Calgary, Alberta--(Newsfile Corp. - January 2, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce …See details»
Fact Sheet - Hemostemix
Contact; Safe Harbour; Privacy Policy; Copyright © 2025 Hemostemix Inc. All rights reserved.See details»